Antivirals market facing generics threat, especially for HIV drugs
12:06 EDT 3 Jul 2012 | thePharmaLetter
Generic copies of branded drugs are predicted to take over the antiviral drugs market, especially in the case of HIV medication, as a series of patent expiries will open opportunities for ambitious companies to seize huge revenue, according to a new..
Original Article: Antivirals market facing generics threat, especially for HIV drugs
More From BioPortfolio on "Antivirals market facing generics threat, especially for HIV drugs"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
